Truway Diagnostic Tools in Primary Care
Enrolling by invitation · Early Phase 1
Conditions studied: Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight, Hypertension, Cardiovascular Disease Acute, Hyperlipidemia, Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD, Peripheral Artery Disease, Metabolic Syndrome, Prediabetes
In brief
This study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 participants will be assigned to use these devices versus standard care over a 6-month period. The primary outcome is improved diagnostic accuracy and patient outcomes. The study, led by Truway Health, Inc., aims to enhance accessible healthcare solutions starting at a New York site, with potential expansion to Miami.
Key facts
- Study ID
- NCT07209527
- Run by
- Truway Health, Inc.
- People needed
- 200
- Starts
- 2025-10-01
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2025-10-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 to 75 years, inclusive
- Ability to understand the study procedures and provide written informed consent
- Diagnosis of the target condition according to established clinical or diagnostic criteria
- Stable treatment regimen (pharmacologic or non-pharmacologic) for at least 4 weeks prior to screening
- Willingness and ability to comply with all study visits, procedures, and follow-up assessments -
You may not qualify if…
- Pregnancy or breastfeeding at the time of enrollment
- Known hypersensitivity to any components of the investigational intervention
- Uncontrolled or unstable comorbid conditions (for example, cardiovascular, hepatic, renal, or psychiatric disorders)
- Participation in another interventional clinical trial within the past 3 months
- Cognitive impairment or language barrier that would preclude valid informed consent or reliable reporting
Where it is running
- Truway Health, Inc. — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.